This Article
Right arrow Full Text (PDF)
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HARRIS, W. H.
Right arrow Articles by DESANCTIS, R. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by HARRIS, W. H.
Right arrow Articles by DESANCTIS, R. W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?
Journal of Bone and Joint Surgery, 1974;56:1552-1562.
© 1974 by The Journal of Bone and Joint Surgery, Inc


Comparison of Warfarin, Low-Molecular-Weight Dextran, Aspirin, and Subcutaneous Heparin in Prevention of Venous Thromboembolism following Total Hip Replacement

WILLIAM H. HARRIS M.D.1, EDWIN W. SALZMAN M.D.1, CHRISTOS ATHANASOULIS M.D.1, ARTHUR C. WALTMAN M.D.1, STANLEY BAUM M.D.1, and ROMAN W. DESANCTIS M.D.1

1 From the Departments of Orthopaedic Surgery, Radiology, and Medicine of the Massachusetts General Hospital; The Department of Surgery of the Beth Israel Hospital; and the Departments of Orthopaedic Surgery, Radiology, Surgery, and Medicine of the Harvard Medical School, Boston

In a prospective study of 187 patients without known prior phlebitis who underwent total hip replacement, we compared the efficacy of warfarin, low-molecular-weight dextran, aspirin, and subcutaneous heparin for prevention of postoperative venous thrombi. Detection of thrombi was by phlebography. Warfarin dextran, and aspirin were superior to heparin. There was no significant difference between the effects of warfarin, dextran, and aspirin on the number of patients with fresh thrombi. In reducing the number of thrombi formed, warfarin and dextran were superior to aspirin. For reduction of the prevalence of thrombi in the thigh, the three drugs were equally effective. Significantly fewer bleeding complications occurred with aspirin than with warfarin. Even in patients who received warfarin, dextran, or aspirin, the prevalence of fresh thrombi was high. Thrombi often formed in the thigh without an associated calf thrombus. Fifty-one of fifty-six episodes of thromboembolic disease were clinically silent at the time of detection. The prophylactic use of warfarin or aspirin, followed by warfarin treatment if a thrombus was detected on phlebograms, provided effective protection against pulmonary embolism.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JBJSHome page
J. R. Lieberman and W. K. Hsu
Prevention of Venous Thromboembolic Disease After Total Hip and Knee Arthroplasty
J. Bone Joint Surg. Am., September 1, 2005; 87(9): 2097 - 2112.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
W. H. Geerts, G. F. Pineo, J. A. Heit, D. Bergqvist, M. R. Lassen, C. W. Colwell, and J. G. Ray
Prevention of Venous Thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest, September 1, 2004; 126(3_suppl): 338S - 400S.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
C. A. Athanasoulis
Vascular Radiology: Looking into the Past to Learn about the Future
Radiology, February 1, 2001; 218(2): 317 - 322.
[Full Text]


Home page
ChestHome page
W. H. Geerts, J. A. Heit, G. P. Clagett, G. F. Pineo, C. W. Colwell, F. A. Anderson Jr., and H. B. Wheeler
Prevention of Venous Thromboembolism
Chest, January 1, 2001; 119(1_suppl): 132S - 175S.
[Full Text] [PDF]


Home page
JBJSHome page
K. B. Freedman, K. R. Brookenthal, R. H. Fitzgerald, S. Williams, and J. H. Lonner
A Meta-Analysis of Thromboembolic Prophylaxis Following Elective Total Hip Arthroplasty
J. Bone Joint Surg. Am., July 1, 2000; 82(7): 929 - 929.
[Abstract] [Full Text]


Home page
JBJSHome page
C. J. DELLA VALLE, L. M. JAZRAWI, J. IDJADI, R. N. HIEBERT, S. A. STUCHIN, D. J. STEIGER, and P. E. DI CESARE
Anticoagulant Treatment of Thromboembolism with Intravenous Heparin Therapy in the Early Postoperative Period Following Total Joint Arthroplasty
J. Bone Joint Surg. Am., February 1, 2000; 82(2): 207 - 12.
[Abstract] [Full Text]


Home page
JBJSHome page
C. W. COLWELL, D. K. COLLIS, R. PAULSON, J. W. McCUTCHEN, G. T. BIGLER, S. LUTZ, and M. E. HARDWICK
Comparison of Enoxaparin and Warfarin for the Prevention of Venous Thromboembolic Disease After Total Hip Arthroplasty. Evaluation During Hospitalization and Three Months After Discharge
J. Bone Joint Surg. Am., July 1, 1999; 81(7): 932 - 40.
[Abstract] [Full Text]


Home page
Vasc MedHome page
G. Agnelli
Postdischarge prophylaxis for venous thromboembolism among high-risk surgery patients
Vascular Medicine, February 1, 1998; 3(1): 51 - 56.
[Abstract] [PDF]


Home page
JBJSHome page
C. W. FRANCIS, V. D. PELLEGRINI JR., S. TOTTERMAN, A. D. BOYD JR., V. J. MARDER, K. M. LIEBERT, B. N. STULBERG, D. C. AYERS, A. ROSENBERG, C. KESSLER, et al.
Prevention of Deep-Vein Thrombosis after Total Hip Arthroplasty. Comparison of Warfarin and Dalteparin
J. Bone Joint Surg. Am., September 1, 1997; 79(9): 1365 - 72.
[Abstract] [Full Text]


Home page
JBJSHome page
G. H. WESTRICH and T. P. SCULCO
Prophylaxis against Deep Venous Thrombosis after Total Knee Arthroplasty. Pneumatic Plantar Compression and Aspirin Compared with Aspirin Alone
J. Bone Joint Surg. Am., June 1, 1996; 78(6): 826 - 34.
[Abstract] [Full Text]


Home page
Med Decis MakingHome page
K. Klein and S. G. Pauker
Recurrent Deep Venous Thrombosis in Pregnancy: Analysis of the Risks and Benefits of Anticoagulation
Med Decis Making, January 1, 1981; 1(2): 181 - 202.
[PDF]